Viewing Opinion | StockChase
Novartis AG (NVS-N) opinion on 2017-04-20

Last Price Recorded: 84.2800 on 2017-11-21

ON STOCKCHASE SINCE Jun 2001

biotechnology/pharmaceutical
BUY

Mark Grammer
Novartis AG was $73.620 at time of opinion
Owned : Yes

It is a really strong global pharma company.  They are turning around their eye care business acquisition and their cardiac drug which had a bungled launch.  If they are successful they will do quite well.  It could be a blockbuster.

BULLISH on GLOBAL STOCKS

All opinions for NVS-N (36)

9 BUY
8 COMMENT
3 DON'T BUY
1 HOLD
1 PARTIAL BUY
6 PAST TOP PICK
6 TOP PICK
1 WAIT
1 WATCH
View All

More experts covering NVS-N

SAVE
Add NVS-N to Watch List

All opinions for NVS-N (36)

9 BUY
8 COMMENT
3 DON'T BUY
1 HOLD
1 PARTIAL BUY
6 PAST TOP PICK
6 TOP PICK
1 WAIT
1 WATCH
View All

More experts covering NVS-N

SAVE
Add NVS-N to Watch List

No Comments.


You must be logged in to comment.

Successfully Saved Company